Residual fibrous masses in treated Hodgkin's disease - PubMed (original) (raw)
Residual fibrous masses in treated Hodgkin's disease
J L Chen et al. Cancer. 1987.
Abstract
Of nine patients with residual masses following therapy for Hodgkin's disease (HD), eight had nodular sclerosing HD, and one had mixed cellularity HD. One patient had Stage II disease, seven had Stage III, and one had Stage IV. Seven patients presented with bulky mediastinal disease. Regardless of the initial therapy used residual masses in the mediastinum and/or peripheral locations stabilized in 1 to 8 months. Between 5 and 10 months after initiation of therapy, five patients underwent resection of mediastinal or paratracheal masses; three patients had resection of peripheral masses, and one patient underwent laparatomy. Microscopically, the resected masses were hyalinized tissue showing a characteristic nodular configuration without evidence of active HD. Stable residual mass lesions occurring after therapy for HD should not be assumed to represent recalcitrant malignancy, as they may show only fibrosis.
Similar articles
- Monitoring bulky mediastinal disease with gallium-67, CT-scan and magnetic resonance imaging in Hodgkin's disease and high-grade non-Hodgkin's lymphoma.
Zinzani PL, Zompatori M, Bendandi M, Battista G, Fanti S, Barbieri E, Gherlinzoni F, Rimondi MR, Frezza G, Pisi P, Merla E, Gozzetti A, Canini R, Monetti N, Babini L, Tura S. Zinzani PL, et al. Leuk Lymphoma. 1996 Jun;22(1-2):131-5. doi: 10.3109/10428199609051740. Leuk Lymphoma. 1996. PMID: 8724540 Clinical Trial. - Recurrent Hodgkin's disease after bone marrow transplantation.
Shahab I, Greer JP, Beeker TA, Wolff SN, Collins RD, Cousar JB. Shahab I, et al. Am J Clin Pathol. 1997 Jan;107(1):74-80. doi: 10.1093/ajcp/107.1.74. Am J Clin Pathol. 1997. PMID: 8980371 - Composite lymphoma. A clinicopathologic analysis of nine patients with Hodgkin's disease and B-cell non-Hodgkin's lymphoma.
Gonzalez CL, Medeiros LJ, Jaffe ES. Gonzalez CL, et al. Am J Clin Pathol. 1991 Jul;96(1):81-9. doi: 10.1093/ajcp/96.1.81. Am J Clin Pathol. 1991. PMID: 2069139 - Hodgkin's disease following non-Hodgkin's lymphoma. A clinicopathologic and immunophenotypic study of nine cases.
Zarate-Osorno A, Medeiros LJ, Kingma DW, Longo DL, Jaffe ES. Zarate-Osorno A, et al. Am J Surg Pathol. 1993 Feb;17(2):123-32. Am J Surg Pathol. 1993. PMID: 8422110 Review. - Thymic hyperplasia following successful treatment for nodular-sclerosing Hodgkin's disease.
Scheinpflug K, Schmitt J, Jentsch-Ullrich K, Roessner A, Franke A. Scheinpflug K, et al. Leuk Lymphoma. 2003 Sep;44(9):1615-7. doi: 10.3109/10428190309178787. Leuk Lymphoma. 2003. PMID: 14565667 Review.
Cited by
- Whole-body MRI versus an [18F]FDG-PET/CT-based reference standard for early response assessment and restaging of paediatric Hodgkin's lymphoma: a prospective multicentre study.
Spijkers S, Littooij AS, Kwee TC, Tolboom N, Beishuizen A, Bruin MCA, Enríquez G, Sábado C, Miller E, Granata C, de Lange C, Verzegnassi F, de Keizer B, Nievelstein RAJ. Spijkers S, et al. Eur Radiol. 2021 Dec;31(12):8925-8936. doi: 10.1007/s00330-021-08026-1. Epub 2021 May 22. Eur Radiol. 2021. PMID: 34021390 Free PMC article. - Mediastinal large-cell lymphoma with sclerosis (MLCLS).
Rohatiner AZ, Whelan JS, Ganjoo RK, Norton AJ, Wilson A, Lister TA. Rohatiner AZ, et al. Br J Cancer. 1994 Mar;69(3):601-4. doi: 10.1038/bjc.1994.111. Br J Cancer. 1994. PMID: 8123496 Free PMC article. - MRI-based long-term follow-up of indolent orbital lymphomas after curative radiotherapy: imaging remission criteria and volumetric regression kinetics.
Hoffmann C, Mohr C, Johansson P, Eckstein A, Huettmann A, von Tresckow J, Göricke S, Deuschl C, Poettgen C, Gauler T, Guberina N, Moliavi S, Bechrakis N, Stuschke M, Guberina M. Hoffmann C, et al. Sci Rep. 2023 Mar 23;13(1):4792. doi: 10.1038/s41598-023-31941-w. Sci Rep. 2023. PMID: 36959374 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical